Alleima AB (publ) (FRA:M46)
Germany · Delayed Price · Currency is EUR 6.16
-0.02 (-0.40%)
At close: Aug 1, 2025, 10:00 PM CET
Verve Therapeutics Revenue
Alleima AB had revenue of 4.77B SEK in the quarter ending June 30, 2025, a decrease of -11.08%. This brings the company's revenue in the last twelve months to 19.51B, down -1.26% year-over-year. In the year 2024, Alleima AB had annual revenue of 19.69B, down -4.73%.
Revenue (ttm)
19.51B SEK
Revenue Growth
-1.26%
P/S Ratio
0.88
Revenue / Employee
3.09M SEK
Employees
6,309
Market Cap
1.53B USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.69B | -978.00M | -4.73% |
| Dec 31, 2023 | 20.67B | 2.26B | 12.30% |
| Dec 31, 2022 | 18.41B | 4.56B | 32.92% |
| Dec 31, 2021 | 13.85B | -78.00M | -0.56% |
| Dec 31, 2020 | 13.93B | -1.73B | -11.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Siemens Energy AG | 37.44B |
| Rheinmetall AG | 10.48B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Deutsche Bank Aktiengesellschaft | 30.07B |